LU80886A1 - 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique - Google Patents

6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique

Info

Publication number
LU80886A1
LU80886A1 LU80886A LU80886A LU80886A1 LU 80886 A1 LU80886 A1 LU 80886A1 LU 80886 A LU80886 A LU 80886A LU 80886 A LU80886 A LU 80886A LU 80886 A1 LU80886 A1 LU 80886A1
Authority
LU
Luxembourg
Prior art keywords
methylmercaptomethylergolines
methoxymethyl
propyl
therapeutic use
related compounds
Prior art date
Application number
LU80886A
Other languages
English (en)
French (fr)
Inventor
E Kornfeld
N Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU80886A1 publication Critical patent/LU80886A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU80886A 1978-02-08 1979-02-06 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique LU80886A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,978 US4166182A (en) 1978-02-08 1978-02-08 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (1)

Publication Number Publication Date
LU80886A1 true LU80886A1 (fr) 1979-06-07

Family

ID=25366703

Family Applications (2)

Application Number Title Priority Date Filing Date
LU80886A LU80886A1 (fr) 1978-02-08 1979-02-06 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique
LU88294C LU88294I2 (fr) 1978-02-08 1993-06-09 Pergolide et ses sels pharmaceutiquement acceptable

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU88294C LU88294I2 (fr) 1978-02-08 1993-06-09 Pergolide et ses sels pharmaceutiquement acceptable

Country Status (36)

Country Link
US (1) US4166182A (pl)
EP (1) EP0003667B1 (pl)
JP (1) JPS54115400A (pl)
AR (1) AR228341A1 (pl)
AT (1) AT371817B (pl)
AU (1) AU523172B2 (pl)
BE (1) BE873883A (pl)
BG (1) BG30474A3 (pl)
CA (1) CA1114368A (pl)
CH (1) CH639088A5 (pl)
CS (1) CS203951B2 (pl)
DD (1) DD141928A5 (pl)
DE (2) DE19375112I2 (pl)
DK (1) DK147362C (pl)
EG (1) EG14076A (pl)
ES (1) ES477547A1 (pl)
FI (1) FI65777C (pl)
FR (1) FR2416891A1 (pl)
GB (1) GB2014140B (pl)
GR (1) GR72776B (pl)
HU (1) HU179970B (pl)
IE (1) IE47827B1 (pl)
IL (1) IL56581A (pl)
LU (2) LU80886A1 (pl)
MX (2) MX5995E (pl)
MY (1) MY8500597A (pl)
NL (1) NL930106I2 (pl)
NZ (1) NZ189561A (pl)
PH (1) PH14903A (pl)
PL (3) PL126313B1 (pl)
PT (1) PT69172B (pl)
RO (3) RO81856A (pl)
SU (1) SU912045A3 (pl)
UA (1) UA6082A1 (pl)
YU (1) YU28279A (pl)
ZA (1) ZA79453B (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4551529A (en) * 1983-10-06 1985-11-05 Warner-Lambert Company Guanine-N7 -oxide
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
DE3868866D1 (de) * 1987-11-20 1992-04-09 Erba Carlo Spa Ergolinderivate mit antiparkinsonwirkung.
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
DE3938701A1 (de) * 1989-11-20 1991-05-23 Schering Ag Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
ES2082959T3 (es) * 1990-09-28 1996-04-01 I F L O S A S Di Giorgio E Ald Procedimiento para desarrollar la sintesis de una droga contraceptiva y de control del ciclo menstrual que tiene propiedades anticinetosicas, oncostaticas y terapeuticas para el tratamiento de los tumores de mama y melanomas.
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US5463060A (en) 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
IT1307934B1 (it) * 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
AU2635599A (en) * 1999-03-17 2000-10-04 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US6388079B1 (en) 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
ES2325880T3 (es) 2001-06-08 2009-09-23 Ipsen Pharma Analogos quimericos de somatostatina-dopamina.
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
DE60324776D1 (de) * 2002-03-15 2009-01-02 Antibioticos Spa Verfahren zur synthese von pergolid
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2113504A1 (en) * 2008-04-29 2009-11-04 LEK Pharmaceuticals D.D. Preparation of N-6 demethylated, 9,10-dihydrolysergic acid alkyl esters
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
US9777039B2 (en) 2012-11-01 2017-10-03 Ipsen Pharma S.A.S. Somatostatin analogs and dimers thereof
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline

Also Published As

Publication number Publication date
BE873883A (fr) 1979-08-02
IL56581A0 (en) 1979-05-31
JPS54115400A (en) 1979-09-07
DD141928A5 (de) 1980-05-28
DE2963320D1 (en) 1982-09-02
PH14903A (en) 1982-01-29
FI790351A (fi) 1979-08-09
HU179970B (en) 1983-01-28
NL930106I2 (nl) 1997-02-03
RO81857B (ro) 1983-05-30
DK147362C (da) 1988-06-27
ES477547A1 (es) 1980-04-16
GB2014140A (en) 1979-08-22
FR2416891A1 (fr) 1979-09-07
NL930106I1 (nl) 1993-10-18
AR228341A1 (es) 1983-02-28
GR72776B (pl) 1983-12-05
EG14076A (en) 1983-12-31
EP0003667B1 (en) 1982-07-14
PL126313B1 (en) 1983-07-30
AU523172B2 (en) 1982-07-15
PT69172B (pt) 1992-05-29
SU912045A3 (ru) 1982-03-07
AU4391779A (en) 1979-08-16
PL124704B1 (en) 1983-02-28
MX5995E (es) 1984-09-18
LU88294I2 (fr) 1994-05-04
RO81857A (ro) 1983-06-01
EP0003667A1 (en) 1979-08-22
UA6082A1 (uk) 1994-12-29
PL120849B1 (en) 1982-03-31
DK51379A (da) 1979-09-18
IL56581A (en) 1982-05-31
JPS6363544B2 (pl) 1988-12-07
US4166182A (en) 1979-08-28
ATA91479A (de) 1982-12-15
AT371817B (de) 1983-08-10
IE47827B1 (en) 1984-06-27
RO81856A (ro) 1983-06-01
RO76889A (ro) 1981-08-30
GB2014140B (en) 1982-08-04
RO81856B (ro) 1983-05-30
IE790232L (en) 1979-08-08
CH639088A5 (fr) 1983-10-31
CA1114368A (en) 1981-12-15
DK147362B (da) 1984-07-02
CS203951B2 (en) 1981-03-31
FI65777B (fi) 1984-03-30
PT69172A (en) 1979-03-01
FR2416891B1 (pl) 1981-10-16
FI65777C (fi) 1984-07-10
PL213283A1 (pl) 1980-02-25
BG30474A3 (en) 1981-06-15
ZA79453B (en) 1980-09-24
MY8500597A (en) 1985-12-31
DE19375112I2 (de) 2003-06-12
YU28279A (en) 1983-02-28
MX9203107A (es) 1992-07-31
NZ189561A (en) 1981-12-15

Similar Documents

Publication Publication Date Title
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE879586A (fr) Phosphinylalcanoyl prolines, leur preparation et leur utilisation
BE877394A (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE885255A (fr) Composes de 10-deazaminopterine, leur preparation et leur utilisation
FR2504931B1 (fr) Ionomeres modifies, leur preparation et leur utilisation
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
FR2439197B1 (fr) 1-thia-3-aza-4-ones, substituees, leur preparation et leur utilisation en agriculture
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
LU81437A1 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
BE876680A (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE877390A (fr) R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylamines et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique